These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 667872)

  • 1. Radionuclide angiography for the evaluation of anthracycline therapy.
    Kennedy JW; Sorensen SG; Ritchie JL; Folland ED; Hamilton GW
    Cancer Treat Rep; 1978 Jun; 62(6):941-3. PubMed ID: 667872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time- and dose-dependent changes in ejection fraction determined by radionuclide angiography after anthracycline therapy.
    Singer JW; Narahara KA; Ritchie JL; Hamilton GW; Kennedy JW
    Cancer Treat Rep; 1978 Jun; 62(6):945-8. PubMed ID: 667873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time- and dose-dependent changes in ejection fraction after anthracycline therapy.
    Narahara KA; Singer JW; Ritchie JL; Williams DL; Hamilton GW; Kennedy JW
    J Cardiovasc Pharmacol; 1979; 1(4):395-401. PubMed ID: 94617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of left ventricular function (ejection fraction and segmental wall motion) by single pass radioisotope angiography.
    Jengo JA; Mena I; MacDonald N; Criley JM
    Int J Nucl Med Biol; 1979; 6(1):35-44. PubMed ID: 478757
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anthracycline cardiotoxicity].
    Finolezzi E; Torromeo C; Vincenzi B; Avvisati G
    Clin Ter; 2003; 154(2):115-21. PubMed ID: 12856371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amsacrine cardiotoxicity: assessment of ventricular function by radionuclide angiography.
    Vorobiof DA; Iturralde M; Falkson G
    Cancer Treat Rep; 1983 Dec; 67(12):1115-7. PubMed ID: 6689141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left-ventricular ejection fraction and segmental wall motion by peripheral first-pass radionuclide angiography.
    Hecht HS; Mirell SG; Rolett EL; Blahd WH
    J Nucl Med; 1978 Jan; 19(1):17-23. PubMed ID: 621557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of the cardiac toxicity of 4'-deoxy-doxorubicin.
    Villani F; Galimberti M; Comazzi R; Crippa F; Bonfante V; Ferrari L; Pacciarini MA
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):185-9. PubMed ID: 3403095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplified method of determining left ventricular ejection fraction from a radionuclide bolus.
    Hannan WJ; Hare RJ; Hughes SH; Scorgie RE; Muir AL
    Eur J Nucl Med; 1977 Jun; 2(2):71-4. PubMed ID: 891561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global and regional assessment of cardiac performance by ECG-gated radionuclide blood pool imaging.
    van Aswegen A; Kleynhans PH; Lötter MG; Minnaar PC; Iturralde M
    S Afr Med J; 1979 Jul; 56(2):50-3. PubMed ID: 384565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of anthracycline-induced cardiotoxicity.
    Jannazzo A; Hoffman J; Lutz M
    Ann Pharmacother; 2008 Jan; 42(1):99-104. PubMed ID: 18094345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of radionuclide angiocardiography in the treatment of patients receiving doxorubicin-based chemotherapy: a reassessment.
    Dreicer R; Karwal MW; Midence G; Davis CS; Nettleman M
    Am J Clin Oncol; 1997 Apr; 20(2):132-7. PubMed ID: 9124185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy.
    Blaes AH; Rehman A; Vock DM; Luo X; Menge M; Yee D; Missov E; Duprez D
    Vasc Health Risk Manag; 2015; 11():591-4. PubMed ID: 26648730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systolic time intervals in monitoring for anthracycline cardiomyopathy in pediatric patients.
    Hutchinson RJ; Bailey C; Wood D; Donaldson MH
    Cancer Treat Rep; 1978 Jun; 62(6):907-10. PubMed ID: 667866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of left ventricular performance by single crystal gamma camera and first pass radionuclide angiography (author's transl)].
    Büll U; Kleinhans E; Cyran J; Strauer BE
    Herz; 1980 Jun; 5(3):133-45. PubMed ID: 7461587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radionuclide angiocardiography, a noninvasive method for evaluating left ventricular ejection fraction and regional wall motion; comparison with contrast left ventricular angiography.
    Kostuk WJ; Chamberlain MJ; Sang HC
    Can Med Assoc J; 1978 Oct; 119(8):877-83. PubMed ID: 757954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probe radiocardiography: validation of a technique to routinely determine left ventricular ejection fraction.
    Floyd JL; Sonnemaker RE; Bode RF
    Clin Nucl Med; 1979 Oct; 4(10):428-36. PubMed ID: 498674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of anthracycline cardiotoxicity.
    Bristow MR; Mason JW; Daniels JR
    Cancer Treat Rep; 1978 Oct; 62(10):1607-8. PubMed ID: 709565
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of heart minute volume and ejection fraction with a new radiocardiographic study method. Comparative studies with conventional results].
    Klein CP; Brill G; Oberhausen E; Bette L
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():221-23. PubMed ID: 611949
    [No Abstract]   [Full Text] [Related]  

  • 20. Left ventricular function in patients with coronary artery disease assessed by gated tomographic myocardial perfusion images. Comparison with assessment by contrast ventriculography and first-pass radionuclide angiography.
    Williams KA; Taillon LA
    J Am Coll Cardiol; 1996 Jan; 27(1):173-81. PubMed ID: 8522692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.